Cargando…

Influence of severity of illness on neutrophil gelatinase-associated lipocalin performance as a marker of acute kidney injury: a prospective cohort study of patients with sepsis

BACKGROUND: The role of neutrophil gelatinase-associated lipocalin (NGAL) as a diagnostic marker for acute kidney injury (AKI) in sepsis is still debated. We hypothesized that in sepsis, the performance of serum(s) and urinary(u) NGAL can be negatively impacted by severity of illness and inflammatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vanmassenhove, Jill, Glorieux, Griet, Lameire, Norbert, Hoste, Eric, Dhondt, Annemieke, Vanholder, Raymond, Van Biesen, Wim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352556/ https://www.ncbi.nlm.nih.gov/pubmed/25868473 http://dx.doi.org/10.1186/s12882-015-0003-y

Ejemplares similares

Urinary output and fractional excretion of sodium and urea as indicators of transient versus intrinsic acute kidney injury during early sepsis
por: Vanmassenhove, Jill, et al.
Publicado: (2013)

Prognostic robustness of serum creatinine based AKI definitions in patients with sepsis: a prospective cohort study
por: Vanmassenhove, Jill, et al.
Publicado: (2015)

The cell cycle biomarkers: promising research, but do not oversell them
por: Lameire, Norbert, et al.
Publicado: (2016)

Pro/con debate: Continuous versus intermittent dialysis for acute kidney injury: a never-ending story yet approaching the finish?
por: Vanholder, Raymond, et al.
Publicado: (2011)

The prevention of acute kidney injury an in-depth narrative review: Part 2: Drugs in the prevention of acute kidney injury
por: Lameire, Norbert, et al.
Publicado: (2009)

The prevention of acute kidney injury: an in-depth narrative review Part 1: volume resuscitation and avoidance of drug- and nephrotoxin-induced AKI
por: Lameire, Norbert, et al.
Publicado: (2008)

Does the Adequacy Parameter Kt/V(urea) Reflect Uremic Toxin Concentrations in Hemodialysis Patients?
por: Eloot, Sunny, et al.
Publicado: (2013)

Measured Glomerular Filtration Rate: The Query for a Workable Golden Standard Technique
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

Acute kidney injury in critically ill cancer patients: an update
por: Lameire, Norbert, et al.
Publicado: (2016)

Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients
por: Eloot, Sunny, et al.
Publicado: (2017)

Dose of dialysis in the intensive care unit: is the venom in the dose or in the clinical experience?
por: Lameire, Norbert, et al.
Publicado: (2009)

Contribution of Hypoalbuminemia and Anemia to the Prognostic Value of Plasma p-Cresyl Sulfate and p-Cresyl Glucuronide for Cardiovascular Outcome in Chronic Kidney Disease
por: Verbeke, Francis, et al.
Publicado: (2022)

Disaster nephrology: a new concept for an old problem
por: Sever, Mehmet Sukru, et al.
Publicado: (2015)

Clinical application value of serum neutrophil gelatinase-associated lipocalin in neonatal sepsis
por: Cai, Qun, et al.
Publicado: (2022)

Uraemic toxins and cardiovascular disease: in vitro research versus clinical outcome studies
por: Vanholder, Raymond, et al.
Publicado: (2008)

Development of a MALDI MS‐based platform for early detection of acute kidney injury
por: Carrick, Emma, et al.
Publicado: (2016)

Protein-Bound Uremic Toxin Profiling as a Tool to Optimize Hemodialysis
por: Eloot, Sunny, et al.
Publicado: (2016)

Plasma and urine neutrophil gelatinase-associated lipocalin as markers of acute kidney injury in critically ill adults
por: Matsa, R, et al.
Publicado: (2012)

Urinary neutrophil gelatinase-associated lipocalin in critically ill surgical cancer patients
por: Delfino Duarte, Pericles Almeida, et al.
Publicado: (2015)

Proenkephalin, Neutrophil Gelatinase-Associated Lipocalin, and Estimated Glomerular Filtration Rates in Patients With Sepsis
por: Kim, Hanah, et al.
Publicado: (2017)

Where and When To Inject Low Molecular Weight Heparin in Hemodiafiltration? A Cross Over Randomised Trial
por: Dhondt, Annemieke, et al.
Publicado: (2015)

Association of peripheral blood neutrophil gelatinase‐associated lipocalin levels with bone marrow neutrophil gelatinase‐associated lipocalin levels and neutrophil count in hematologic malignancy
por: Cho, Chi‐Hyun, et al.
Publicado: (2019)

Neutrophil Gelatinase-Associated Lipocalin Levels During Pneumoperitoneum
por: Kiseli, Mine, et al.
Publicado: (2017)

Neutrophil gelatinase–associated lipocalin as an immunomodulator in endocrine hypertension
por: Araos, Patricio, et al.
Publicado: (2022)

Use of admission serum neutrophil gelatinase-associated lipocalin (NGAL) concentrations as a marker of sepsis and outcome in neonatal foals
por: Laurberg, Malene, et al.
Publicado: (2023)

Neutrophil gelatinase-associated lipocalin predicts acute kidney injury in critically ill patients
por: Núñez, K, et al.
Publicado: (2010)

Urinary Neutrophil Gelatinase-Associated Lipocalin in Critically Ill Patients With Coronavirus Disease 2019
por: Komaru, Yohei, et al.
Publicado: (2020)

Plasma Neutrophil Gelatinase-Associated Lipocalin Is Useful for Predicting Mortality in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2021)

Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis
por: Deltombe, Olivier, et al.
Publicado: (2015)

Contribution of the uremic milieu to an increased pro-inflammatory monocytic phenotype in chronic kidney disease
por: Borges Bonan, Natalia, et al.
Publicado: (2019)

Neutrophil Gelatinase-Associated Lipocalin as a Marker for Renal Dysfunction Detection in Critically Ill Patients with Increased Intraabdominal Pressure
por: Puiac, Claudiu, et al.
Publicado: (2017)

The utility of neutrophil gelatinase-associated Lipocalin (NGAL) as a marker of acute kidney injury (AKI) in critically ill patients
por: Khawaja, Shabnum, et al.
Publicado: (2019)

Evaluation of Neutrophil Gelatinase-associated Lipocalin and Cystatin C as Early Markers of Diabetic Nephropathy
por: Siddiqi, Zeba, et al.
Publicado: (2017)

Plasma Neutrophil Gelatinase-Associated Lipocalin as a Marker of Tubular Damage in Diabetic Nephropathy
por: Kim, So Young, et al.
Publicado: (2018)

Clinical assessment of neutrophil gelatinase-associated lipocalin as a potential diagnostic marker for neonatal sepsis: a prospective cohort study
por: Midan, Dina, et al.
Publicado: (2022)

Neutrophil gelatinase-associated lipocalin in ICU patients developing oliguria
por: Roman, A, et al.
Publicado: (2011)

Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer
por: Candido, Saverio, et al.
Publicado: (2014)

Urinary Excretion of Neutrophil Gelatinase-Associated Lipocalin in Diabetic Rats
por: Arellano-Buendía, Abraham Said, et al.
Publicado: (2014)

The origin of plasma neutrophil gelatinase-associated lipocalin in cardiac surgery
por: Passov, Arie, et al.
Publicado: (2019)

Role of neutrophil gelatinase-associated lipocalin in renal cell carcinoma
por: Che, Kai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vs1n56ibadb87pott7unmkhb5i